Ischemic heart disease Board decisions

The Veteran's coronary artery disease is rated at a 30 percent rating prior to September 20, 2022. From September 20, 2022 onwards, the Veteran does not meet the criteria for a higher rating.

The Veteran's mood disorder is granted as it was caused by the medications taken for his service-connected gastroesophageal reflux disease (GERD).,Service connection for left and right knee disabilities is denied due to lack of evidence showing a chronic disability in service or within one year after separation.

The Board dismissed the appeal for service connection for squamous cell various, skin cancer due to the Veteran's withdrawal.,Service connection was granted for diabetes mellitus type II based on presumed exposure to herbicides during active-duty service in Korea.,Service connection was granted for coronary artery disease (CAD) with atrial fibrillation based on presumed exposure to herbicides during active-duty service in Korea.,Service connection was granted for hypertension based on presumed exposure to herbicides during active-duty service in Korea.,Service connection was granted for lymphoma based on presumed exposure to herbicides during active-duty service in Korea.,Service connection was granted for renal adenocarcinoma with renal insufficiency based on presumed exposure to herbicides during active-duty service in Korea.

Service connection is granted for diabetes mellitus, type II, prostate cancer, and coronary artery disease due to herbicide exposure during service in Thailand.,The Veteran's bilateral lower extremity diabetic peripheral neuropathy, erectile dysfunction, and hypertension are also granted as secondary to the service-connected conditions.

The Board has determined that new and relevant evidence has been received to warrant readjudication of the Veteran's claims for service connection for chronic atrial fibrillation/arrhythmia, coronary artery disease, hypertension, and Parkinson's disease. The claims are now remanded due to pre-decisional errors in verifying the Veteran's exposure to herbicide agents during his service.

The Veteran's claims for service connection for coronary artery disease, post-traumatic stress disorder, bilateral hearing loss, and tinnitus have been granted. The decision is based on the presumption of exposure to herbicide agents in Vietnam for CAD, and a positive opinion regarding an in-service stressor for PTSD.

The Veteran's coronary artery disease is rated at a 30 percent rating prior to September 20, 2022. From September 20, 2022 onwards, the Veteran does not meet the criteria for a higher rating.

The Veteran's coronary artery disease is rated at a 30 percent rating prior to September 20, 2022. From September 20, 2022 onwards, the Veteran does not meet the criteria for a higher rating.

The Veteran's claim for a higher rating for his coronary artery/arteriosclerotic heart disease is remanded due to the inadequacy of the April 2022 VA examination.

The Board has decided to remand the claims of entitlement to service connection for ED secondary to service-connected CAD and DM due to a duty-to-assist error. The VA medical opinions obtained were inadequate as they did not address whether the Veteran's ED was caused or aggravated by his service-connected conditions, nor did they consider the potential aggravation of ED by herbicide exposure.

The Board has granted service connection for the Veteran's heart condition, including atherosclerotic cardiovascular disease with congestive heart failure, valvular heart disease, hypertensive heart disease, cardiomyopathy, premature atrial contractions, and coronary artery disease, based on exposure to herbicide agents during his military service in Vietnam.

The Board has denied service connection for diabetes mellitus, Parkinson's disease, hypertension, heart condition, and hypothyroidism as there is no credible evidence of herbicide agent exposure in the Panama Canal Zone during the Veteran's service.

The Board denied the Veteran's claim for a total disability rating based on individual unemployability (TDIU) due to service-connected disabilities, finding that his service-connected conditions did not render him unable to secure or follow substantially gainful employment.

The Board has granted service connection for the Veteran's heart disability, including coronary artery disease with paroxysmal atrial fibrillation, finding that it is related to his active service.

The Board has denied the Veteran's claim for service connection for a heart condition. The claims of entitlement to compensation under 38 U.S.C. § 1151 for back, kidney, headache, left leg numbness, and right leg numbness conditions are remanded.

The Veteran's appeal for an earlier effective date for service connection and a higher rating for CAD prior to February 21, 2018 has been dismissed. The Board granted the earlier effective date in a previous decision.

The Board has granted service connection for coronary artery disease and atrial fibrillation as secondary to the Veteran's service-connected hypertension. The decision is based on a medical opinion that supports this relationship.

The Veteran's claims for a higher rating for his heart disease and TDIU are being remanded due to the need for additional VA examinations and METs testing.

The Veteran withdrew his appeal for service connection of a heart disorder before the Board could make a decision.

The Board has granted an effective date of July 14, 2014 for the grant of service connection for Coronary Artery Disease (CAD) due to exposure to herbicide agents during active duty. The Veteran's claim was received on July 14, 2015, and he is entitled to retroactive benefits based on a presumption of service connection.